Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute of Mental Health (NIMH) |
---|---|
Information provided by: | National Institute of Mental Health (NIMH) |
ClinicalTrials.gov Identifier: | NCT00429546 |
This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.
Condition | Intervention | Phase |
---|---|---|
HIV |
Behavioral: Teaching, Raising, and Communicating with Kids (TRACK) Other: Treatment as usual |
Phase I |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind (Outcomes Assessor), Single Group Assignment, Efficacy Study |
Official Title: | Maternal HIV: Intervention to Assist Disclosure to Children |
Estimated Enrollment: | 160 |
Study Start Date: | September 2007 |
Estimated Study Completion Date: | August 2009 |
Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Intervention: Experimental
Participants will receive a cognitive-behavioral intervention designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child
|
Behavioral: Teaching, Raising, and Communicating with Kids (TRACK)
TRACK is cognitive-behavioral treatment designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child. The treatment consists of three 75-minute sessions that focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure.
|
Control: Active Comparator
Participants will receive treatment as usual
|
Other: Treatment as usual
Treatment as usual includes standard care for HIV infected mothers.
|
HIV is a serious, life threatening illness that requires a lifetime of treatment and disease management. Studies have shown that it can be very difficult for infected mothers to decide whether and/or when to disclose their HIV serostatus to their uninfected children. HIV-infected parents struggle with the fear that their children will be forced to grow up too quickly, become worried or depressed, or be angry with their parents once they learn that their parents have HIV. Family-based intervention programs have been successful in helping facilitate the disclosure process. This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.
Participants in this study will be randomly assigned to either the intervention or a standard of care condition.
The intervention will consist of three 75-minute sessions that will focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure.
Participants will also receive one follow-up phone call from the therapist about 3 weeks after the last session.
Sessions will be scheduled at times that are convenient for the participants and therapists. Follow-up visits will include both mothers and their children, and will be held at Months 3, 6, and 9 following the end of the intervention. Assessments will include readiness to disclose HIV serostatus, mental health indicators, and family functioning.
Ages Eligible for Study: | 6 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Diana L Payne, PhD | 310-794-8127 | dpayne@mednet.ucla.edu |
United States, California | |
University of California, Los Angeles | Recruiting |
Los Angeles, California, United States, 90025 | |
Contact: Diana L. Payne, PhD 310-794-8127 dpayne@mednet.ucla.edu | |
Contact: Tim Castro, BA 310-794-8127 tcastro@mednet.ucla.edu |
Principal Investigator: | Debra A. Murphy, PhD | University of California, Los Angeles |
Responsible Party: | UCLA ( Dr. Debra A. Murphy, Prinicipal Investigator ) |
Study ID Numbers: | R01 MH77493, DAHBR 9A-ASAP |
Study First Received: | January 29, 2007 |
Last Updated: | March 12, 2009 |
ClinicalTrials.gov Identifier: | NCT00429546 History of Changes |
Health Authority: | United States: Federal Government |
Disclosure Serostatus |
HIV Infections Acquired Immunodeficiency Syndrome |